详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Wu, X.[1] ; Xia, L.[1] ; Zhang, K.[2] ; Tang, Y.[3] ; Zhang, G. N.[4]

; Wang, D.[5] ; Lou, H.[6] ; Liu, N.[7] ; Zhang, H.[8] ; Chen, H.[9] ; Wang, K.[10] ; Wei, S.[11] ; Wang, L.[12] ; Gao, K.[13] ; Li, G.[14] ; Zhang, H.[15] ; Hu, Y.[16] ; Zhou, X.[17] ; Wang, Y.[17] ; Wang, Q.[17] ;

机构： [1]Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China [2]Department of Gynecologic Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China [3]Department of Gynecologic Oncology, Chongqing University Cancer Hospital, Chongqing, China [4]Department of Gynecology Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science & Technology of China, Chengdu, China [5]Department of Gynecology, Liaoning Cancer Hospital & Institute, Shenyang, China [6]Department of Gynecological Surgery, Zhejiang Cancer Hospital, Hangzhou, China [7]Department of Gynecology Oncology, Shandong Cancer Hospital & Institute, Jinan, China [8]Department of Gynecology Oncology, Yunnan Cancer Hospital & The Third Affliated Hospital of Kunming Medical University, Kunming, China [9]Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China [10]Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China [11]Comprehensive Internal Medicine, Shanxi Cancer Hospital, Taiyuan, China [12]Department of Gynecology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China [13]Gynecological Oncology, Guangxi Medical University Cancer Hospital, Nanning, China [14]Department of Gynecology Oncology, Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China [15]Department of Gynecology Oncology, Hubei Cancer Hospital, Wuhan, China [16]Department of Gynecology Oncology, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China [17]Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy in women with recurrent or metastatic cervical cancer

文献详情